The Spinal Cord Stimulation (SCS) market saw high-teens growth in FY18, but decelerated in Q418.
The US SCS Market saw another banner year in FY18, growing +17.4% YoY. Market growth was driven by new product launches, expanding indications and ongoing demand for non-narcotic alternatives that address chronic intractable pain and the opioid epidemic.
New Products, Continued Demand Provide SCS Market Tailwinds
SmartTRAK reports that with new products providing a strong tailwind in Q318, the SCS market saw another quarter of strong double-digit growth in both the US and WW, positioning the market for another record year.
Among the many topics covered in the Q318 SCS Market Recap are:
SmartTRAK identifies trends to watch in spinal cord stimulation
With the start of a new year, it's time to look back at 2018 and identify continuing and emerging trends in the market for Spinal Cord Stimulation (SCS) that are likely to shape the landscape in 2019 and beyond.
So what’s on the horizon? Anne Staylor, SmartTRAK Managing Editor, gives her predictions for the top technology and market trends to watch.
Among the many interesting and informative topics covered in the article are:
In an interview with SmartTRAK, B. Todd Sitzman, MD, MPH, President of the North American Neuromodulation Society (NANS), provides a preview of the educational opportunities, key research and emerging technologies that will be at the NANS 22nd Annual meeting to be held January 17-20, 2019 in Las Vegas, NV. Dr. Sitzman expects NANS 2019 to be the biggest meeting yet for the premier neuromodulation society, with up to 3000 attendees and 300+ abstracts presented, organized around the theme of “The Science Behind Successful Outcomes.”
To find out more about the meeting, click on the video below to listen to SmartTRAK’s interview with Dr. Sitzman, recorded via Skype from his office in Hattiesburg, Mississippi (11:53 minutes).
IRVINE, CA (PRWEB) JANUARY 02, 2019
Matt Thomas, General Manager and Vice President of Medtronic’s STIM & Early Intervention business discusses the Company’s growth strategies, plans for innovation, and what’s next in spinal cord stimulation in a podcast interview with SmartTRAK at the American Society of Interventional Pain Physicians (ASIPP) 2018 held March 15-17, 2018 in Orlando, FL
Click the Podcast Link to hear the interview, recorded live at ASIPP 2018. (18:55 minutes.)
To receive a downloadable transcript, click the button below...
SmartTRAK will be represented by Anne Staylor, Managing Editor, Business Intelligence and Senior Director, Advanced Technologies.
At CNS 2107, Anne did an interview with Dr. Ashwini Sharan, President of the Congress of Neurological Surgeons, on The Future of Robotic Spine Surgery, discussing current trends in robotic spine surgery, factors affecting growth in this market and future directions for this technology. To download a transcript of this fascinating interview, please click the button below.
SmartTRAK is excited to be attending #SNIS - Society of Neuro Interventional Surgery's 15th annual meeting on July 23-26 at the Hilton San Francisco Union Square, in San Francisco, California.
SmartTRAK will be represented by Anne Staylor, Managing Editor, Business Intelligence and Senior Director, Advanced Technologies and Christopher McCarthy, Vice President Corporate Accounts, Orthopedics and Neuro. Please contact us if you would like a meeting.
SmartTRAK, the leading source of competitive life sciences intelligence used by the top ten global orthopedic & wound care companies, has published its Q118 US Spinal Cord Stimulation Market Recap.
The US Spinal Cord Stimulation (SCS) market saw another quarter of exceptional growth in Q118, yet the market decelerated QoQ, posting 23% growth vs 24.6% growth in Q417. While seasonal trends were behind the QoQ slowdown ...Among the many topics covered in the full Q118 SCS Market Recap are:
In May 2017, Nevro CEO Rami Elghandour chatted with Anne Staylor, BioMedGPS Managing Editor/Neuro Analyst to discuss dynamics in the global spinal cord stimulation (SCS) market, including trends, drivers, challenges, competition, and opportunity that would influence the Company’s growth.
A fascinating read then, that now has us appraising a year later if Elghandour's expansion predictions came to pass. Is Nevro still the one to beat as the top leader in the neuromodulation field?
or read the interview in full below!
SmartTRAK is the Medtech industry’s only global Insights-as-a-Service solution for the Orthopedics, Wound Care, Regenerative Medicine and Neuro Therapy markets. SmartTRAK’s propriety methodology turns disparate data from hundreds of sources into powerful insights customers can rely on as the trusted source for strategic decision-making. The SmartTRAK enterprise platform includes rich daily updates, comprehensive market coverage and simple-to-use tools and dashboards for market, product and financial analysis. Customers leveraging the SmartTRAK platform also have direct access to market experts for inquiries and advisory services.